Fatigue and Fatty Liver Disease: Causes and Tips

Fatigue and fatty liver disease are closely linked, yet the reasons behind this tiredness are often poorly understood. Fatty liver disease, increasingly referred to as metabolic dysfunction-associated steatotic liver disease (MASLD) and still widely known in the UK as non-alcoholic fatty liver disease (NAFLD), affects the liver's ability to regulate energy efficiently and can trigger low-grade systemic inflammation that leaves people feeling persistently drained. Coexisting conditions such as type 2 diabetes, obstructive sleep apnoea and hypothyroidism frequently compound the problem. This article explains the mechanisms behind fatigue, what else to consider, and when to seek medical advice.

Why does fatty liver disease make you feel so tired?

Fatty liver disease impairs the liver's ability to convert nutrients into usable fuel and triggers release of pro-inflammatory cytokines, both of which contribute to persistent fatigue. Severity of tiredness does not reliably reflect the degree of liver damage.

Fatty liver disease is associated with fatigue through several overlapping mechanisms, though the relationship is multifactorial and not fully understood. The liver plays a central role in converting carbohydrates, fats and proteins into usable fuel, and when hepatocytes become laden with excess fat, this process becomes less efficient. The result is a reduced capacity to maintain stable blood glucose levels and to produce the energy substrates that muscles and the brain depend on throughout the day.

In metabolic dysfunction-associated steatotic liver disease (MASLD), low-grade systemic inflammation is considered an important contributor to tiredness. Many UK clinical resources, including NHS guidance, continue to use the term non-alcoholic fatty liver disease (NAFLD), and the two terms refer to the same condition under different naming conventions. Fat accumulation in liver cells can trigger the release of pro-inflammatory cytokines, including tumour necrosis factor-alpha and interleukin-6, which may act on the central nervous system and contribute to a state sometimes described as sickness behaviour, characterised by fatigue, poor concentration and low mood.

As the condition progresses to metabolic dysfunction-associated steatohepatitis (MASH, formerly non-alcoholic steatohepatitis or NASH), inflammation and early fibrosis place additional strain on liver function. In advanced liver disease, including cirrhosis, the liver's reduced capacity to process ammonia and other metabolic by-products can contribute to cognitive symptoms. In earlier stages of MASLD or MASH without cirrhosis, this mechanism is less established, and fatigue is more likely to reflect systemic inflammation and metabolic disruption.

It is worth noting that the severity of fatigue does not always correlate neatly with the degree of liver damage visible on imaging or biopsy. Some people with mild steatosis report significant tiredness, while others with more advanced disease feel relatively well. This variability makes fatigue an unreliable standalone marker of disease progression, which is why formal clinical assessment remains important.

What other conditions can cause fatigue alongside a fatty liver?

Type 2 diabetes, obstructive sleep apnoea, hypothyroidism and depression frequently coexist with fatty liver disease and independently worsen fatigue. Identifying and treating these conditions can substantially improve energy levels.

Fatigue in people with fatty liver disease is frequently compounded by coexisting conditions that share the same metabolic risk factors, most notably type 2 diabetes, obesity, obstructive sleep apnoea and hypothyroidism. Identifying these conditions matters because treating them can substantially improve energy levels independently of any improvement in liver health.

Type 2 diabetes and insulin resistance are closely linked to MASLD and are themselves potent causes of fatigue. Poorly controlled blood glucose leads to energy fluctuations, while peripheral neuropathy and the psychological burden of managing a long-term condition add further to tiredness. Similarly, obstructive sleep apnoea, which is more prevalent in people with central obesity, causes repeated nocturnal hypoxia and fragmented sleep, producing daytime somnolence that can be severe and is often mistaken for liver-related fatigue.^[13][14]

Hypothyroidism is another important consideration. An underactive thyroid slows metabolism throughout the body, causing fatigue, weight gain and low mood, and it can coexist with fatty liver disease because both conditions are associated with metabolic syndrome. A simple blood test measuring thyroid-stimulating hormone (TSH) and free thyroxine (FT4) can identify this, and treatment with levothyroxine, at a dose guided by blood results and symptoms and monitored over time, is effective for most people, in line with NICE guidance on thyroid disease (NG145).

Depression and anxiety are also significantly more common in people living with chronic liver conditions. The psychological impact of a long-term diagnosis, combined with the neuroinflammatory effects described above, creates a bidirectional relationship between mood and fatigue that warrants assessment in its own right. Anaemia, chronic kidney disease and cardiovascular disease round out the list of conditions a clinician should consider when evaluating persistent tiredness in someone with a known fatty liver diagnosis. A medication review is also worthwhile, as some commonly prescribed medicines, including sedatives and opioids, can contribute to fatigue. Where anaemia is suspected, iron studies alongside a full blood count can help identify the cause. A thorough clinical review, including blood tests and a sleep history, is the appropriate starting point.

Lifestyle changes that may improve both liver health and energy levels

Weight loss of 7 to 10 per cent of body weight, a Mediterranean-style diet and 150 minutes of moderate aerobic activity per week are recommended by NICE (NG49) and the British Society of Gastroenterology. These changes reduce liver fat, lower inflammation and improve energy.

Sustained weight loss of 7 to 10 per cent of body weight is the most evidence-based lifestyle intervention for reducing liver fat, and is recommended in NICE guidance on NAFLD (NG49) and by the British Society of Gastroenterology.^[1] Even modest reductions in body weight can meaningfully decrease hepatic steatosis, lower inflammatory markers and improve insulin sensitivity, all of which contribute to better energy levels over time. Greater weight loss, in the region of 10 per cent or more, may be needed to achieve histological improvement in more advanced disease.^[1]

Dietary quality matters as much as calorie restriction. A Mediterranean-style eating pattern, rich in vegetables, legumes, wholegrains, oily fish and olive oil, has a strong evidence base for liver health and is associated with reduced systemic inflammation. Reducing intake of ultra-processed foods, refined carbohydrates and added sugars is particularly important, as excess free sugars, including fructose, promote hepatic fat synthesis.^[20][21] Alcohol should be minimised or avoided entirely, even in MASLD where alcohol is not the primary cause, because any additional hepatotoxic burden can accelerate disease progression. UK Chief Medical Officers advise that if people choose to drink, they should aim to stay within 14 units per week spread over three or more days; clinicians may recommend abstinence in people with steatohepatitis or advanced fibrosis.

Regular physical activity improves liver fat content, insulin sensitivity and metabolic markers, and can also help with fatigue, with benefits that appear partly independent of weight loss. The UK Chief Medical Officers' Physical Activity Guidelines recommend at least 150 minutes of moderate-intensity aerobic activity per week, alongside muscle-strengthening activities on two or more days.^[5][6] Resistance training in particular has been shown to improve insulin sensitivity and reduce liver fat. Starting gradually and building up is advisable for people who are currently sedentary, as overexertion can temporarily worsen fatigue.

Sleep hygiene deserves specific attention. Establishing consistent sleep and wake times, limiting screen exposure before bed and addressing any underlying sleep disorder such as obstructive sleep apnoea can produce meaningful improvements in daytime energy. For people seeking structured support with weight management, Bolt Pharmacy is a GPhC-registered UK online pharmacy offering online weight-management consultations, with prescriber review and pharmacist support, where a range of clinically appropriate options may be considered.

When should you see a GP about persistent tiredness and liver symptoms?

See your GP if fatigue is persistent, unexplained or accompanied by symptoms such as jaundice, abdominal swelling or unexplained weight loss, which may indicate disease progression. Call 999 immediately if you develop sudden severe abdominal pain, confusion or vomiting blood.

You should see your GP if fatigue is persistent, is significantly affecting your daily life, or is accompanied by any symptoms that suggest worsening liver disease or another serious underlying cause. The NHS advises seeing a GP about tiredness that does not improve with rest or that is unexplained. In the context of a known or suspected fatty liver diagnosis, persistent fatigue warrants a structured clinical review rather than self-management alone.

Symptoms that should prompt a GP appointment without delay include:

• Unexplained weight loss

• Persistent nausea, vomiting or loss of appetite

• Upper right abdominal discomfort or a sensation of fullness

• Yellowing of the skin or whites of the eyes (jaundice)

• Dark urine or pale stools

• Swelling of the abdomen or legs

• Easy bruising or prolonged bleeding

These features may indicate progression to more advanced liver disease, including cirrhosis or its complications, and require prompt investigation. Your GP can arrange blood tests including liver function tests, a full blood count, thyroid function, fasting glucose and HbA1c, a fasting lipid profile, and a FIB-4 score calculation. NICE (NG49) recommends FIB-4 as an initial non-invasive assessment of liver fibrosis risk in primary care, with age-adjusted thresholds used to guide further investigation.^[1] Where FIB-4 results are indeterminate or elevated, a second-line test such as the Enhanced Liver Fibrosis (ELF) score or transient elastography may be arranged, and referral to hepatology considered.^[22][23] Your GP may also arrange tests to exclude other causes of liver disease, such as viral hepatitis serology, ferritin and transferrin saturation (for haemochromatosis), and autoimmune liver markers, where clinically indicated.

If you develop sudden severe abdominal pain, confusion, vomiting blood or black tarry stools, these are potential emergencies and you should call 999 or go to your nearest accident and emergency department immediately. For urgent advice that does not require an emergency response, NHS 111 is available around the clock.

Regular monitoring is important even when symptoms are mild. People with MASLD should have periodic reassessment of their metabolic risk factors, liver function and fibrosis risk, as the condition can progress silently. Proactive engagement with your GP or liver specialist is the most reliable way to catch any deterioration early and to adjust management accordingly.

Frequently Asked Questions